Consult with clients, external IQVIA divisions, and Clinical Pharmacology staff on study design, or other aspects of Clinical Pharmacology projects, and clinical development plans.
Possess a Diploma or degree in Pharmacy from recognized University or institute Statutory University or a Diploma in Pharmacy of a State Govt. AND Have valid registration under the Pharmacy ACT 1948.
Masters/ Integrated Masters in Pharmaceutical Sciences/ MVSc/ Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University.
The candidate must have Post graduate degrees in biomedical sciences, biotechnology relevance to drug delivery, biological therapeutics, pharmaceutical sciences, Biotechnology.
The candidate must have First class post graduate degrees or second-class post graduate with PhD degree in relevance to nano technology, nano-delivery, biological therapeutics, pharmaceutical sciences, Biotechnology.
Applications for a postdoctoral position to study mitochondrial regulation of NK cell activation and tumor immunity. This is for a collaborative project between TIFR Hyderabad and Tata Memorial Cancer Centre.
Designing formulation and process strategies, planning and execution of activities. Development of robust and scalable product within targeted time limits which includes comprehensive reviews of literature, pre-formulation trials, laboratory experiments and ELN writing with detailed observations.
Ipca Laboratories Limited Invites experienced, dynamic, and self motivated candidates. Protocol Preparation and Compilation Report of Process Validation, ANDA, Hold Time Study
Indoco Remedies Ltd., is a fully integrated, research-oriented pharma company engaged in the manufacturing and marketing of Formulations and Active Pharmaceutical Ingredients
The study, published online in The Journal of Nutrition, found that consumption of 1-2 cups of caffeinated coffee per day was linked to a lower risk of death from all causes and death from cardiovascular disease.
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration FDA has approved Dupixent dupilumab for the treatment of adult patients with bullous pemphigoid.
Orion’s collaboration partner Bayer announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended darolutamide, an oral androgen receptor inhibitor , plus androgen deprivation therapy for marketing authorisation in the European Union for the treatment of patients with metastatic hormone-sensitive prostate cancer
A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare autoimmune disease of the peripheral nervous system. This treatment modifies endogenous immune cells such that they can specifically target and eliminate B lymphocytes, which are here the origin of autoimmunity.